Evidence map›Paper›PMID 32552454›Full record

ArticleStatistical methods in medical research2020

Robustness of risk-based allocation of resources for disease prevention.

Mitchell H Gail, David Pee

Abstract read
In one paragraph

Article in Statistical methods in medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mitchell H GailDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0002-3919-3263
David PeeRockville Office, Information Management Services, Inc., Rockville, MD, USA.

Funding

Nutrition, Metabolism, and CancerZIACP010169 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GIERACH, GRETCHEN · 2009 to 2025
$9.2M
Risk prediction methodsZIACP010188 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ALBERT, PAUL · 2010 to 2025
$8.9M
Intramural NIH HHS ZIA CP010188
6 · The paper itself

Abstract

Risk models for disease incidence can be useful for allocating resources for disease prevention if risk assessment is not too expensive. Assume there is a preventive intervention that should be given to everyone, but preventive resources are limited. We optimize risk-based prevention strategies and investigate robustness to modeling assumptions. The optimal strategy defines the proportion of the population to be given risk assessment and who should be offered intervention. The optimal strategy depends on the ratio of available resources to resources needed to intervene on everyone, and on the ratio of the costs of risk assessment to intervention. Risk assessment is not recommended if it is too expensive. Preventive efficiency decreases with decreasing compliance to risk assessment or intervention. Risk measurement error has little effect nor does misspecification of the risk distribution. Ignoring population substructure has small effects on optimal prevention strategy but can lead to modest over- or under-spending. We give conditions under which ignoring population substructure has no effect on optimal strategy. Thus, a simple one-population model offers robust guidance on prevention strategy but requires data on available resources, costs of risk assessment and intervention, population risk distribution, and probabilities of acceptance of risk assessment and intervention.

Indexed as

Resource AllocationCosts and Cost AnalysisMorbidityRisk Factorscost constraintsDisease preventionoptimal prevention strategyrisk-based resource allocationrobustness of prevention strategy to assumptions

Identifiers

PMID32552454
PMCPMC8860617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.